Abstract

BackgroundsMore than 300,000 patients undergo dialysis treatment today in Japan. In these patients, malignant disease is the third leading cause of death (accounting for 9%) following congestive heart failure and infection.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call